David Charles Lubner insider trades: Braveheart Bio (BRVE) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
and 5 more companies
Open-market buys and sales
11 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | BRVE | ↑ Buy | 55,555 | $18.00 | $1000K | Direct | Aug 7, 2026 (0d) |
| Jan 20, 2026 | ACLX | ↓ Sell | 6,000 | $75.00 | $450K | Direct | Jan 20, 2026 (0d) |
| Nov 23, 2022 | PNT | ↑ Buy | 3,600 | $6.85 | $25K | Direct | Nov 28, 2022 (5d) |
| Aug 14, 2015 | TTPH | ↓ Sell10b5-1 | 9,500 | $42.92 | $408K | Direct | Aug 17, 2015 (3d) |
| Jul 14, 2015 | TTPH | ↓ Sell10b5-1 | 7,500 | $48.92 | $367K | Direct | Jul 15, 2015 (1d) |
| Jun 15, 2015 | TTPH | ↓ Sell10b5-1 | 17,500 | $41.45 | $725K | Direct | Jun 16, 2015 (1d) |
| May 14, 2015 | TTPH | ↓ Sell10b5-1 | 15,000 | $39.28 | $589K | Direct | May 18, 2015 (4d) |
| Jun 17, 2014 | TTPH | ↓ Sell10b5-1 | 13,530 | $12.51 | $169K | Direct | Jun 18, 2014 (1d) |
| Mar 6, 2014 | TTPH | ↓ Sell10b5-1 | 4,510 | $13.65 | $62K | Direct | Mar 10, 2014 (4d) |
| Feb 12, 2014 | TTPH | ↓ Sell10b5-1 | 4,506 | $13.92 | $63K | Direct | Feb 13, 2014 (1d) |
| Feb 7, 2014 | TTPH | ↓ Sell | 9,928 | $14.22 | $141K | Direct | Feb 11, 2014 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BRVE insiders
Open-market trades in the last 12 months
About David Charles Lubner's insider trades
David Charles Lubner is a director at Braveheart Bio (BRVE). Since Feb 7, 2014, David has reported 2 open-market purchases worth $1.0M and 9 sales worth $3.0M on SEC Form 4. In the last 12 months: 1 buy ($1000K) and 1 sale ($450K).
7 sales (80% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (37 filings), option exercises (7 filings), shares returned to the company (5 filings), other transactions (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BRVE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.